SONN icon

Sonnet BioTherapeutics
SONN

Overview Fund Trends Analyst Outlook Journalist POV

hedge funds and large institutions have $185K invested in Sonnet BioTherapeutics in 2017 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $
Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$49K
2
-$32K
3
-$28K
4
UBS Group
UBS Group
Switzerland
-$16K
5
Bank of America
Bank of America
North Carolina
-$11K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$46K
2
$37K
3
$32K
4
$28K
5
$22K
6
$11K
7
$6K
8
$3K
9
–
10
–